DNM2 and Parkinson disease: Whether caspase-6 contributes to vascular disease, as it does to neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease, where cleavage of cytoskeletal proteins contributes to axonal degeneration, remains to be determined [13].